As of 2025-07-07, the Relative Valuation of Cytosorbents Corp (CTSO) is (9.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.09 USD, the upside of Cytosorbents Corp based on Relative Valuation is -958.8%.
The range of the Relative Valuation is (9.22) - (9.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.4x - 44.9x | 39.2x |
| Forward P/E multiples | 34.1x - 37.7x | 34.8x |
| Fair Price | (9.22) - (9.53) | (9.36) |
| Upside | -945.8% - -974.1% | -958.8% |
| Date | P/E |
| 2025-07-03 | -4.31 |
| 2025-07-02 | -3.95 |
| 2025-07-01 | -5.10 |
| 2025-06-30 | -5.06 |
| 2025-06-27 | -4.86 |
| 2025-06-26 | -4.66 |
| 2025-06-25 | -4.74 |
| 2025-06-24 | -4.74 |
| 2025-06-23 | -4.98 |
| 2025-06-20 | -4.66 |
| 2025-06-18 | -4.59 |
| 2025-06-17 | -4.74 |
| 2025-06-16 | -4.82 |
| 2025-06-13 | -4.31 |
| 2025-06-12 | -4.23 |
| 2025-06-11 | -4.31 |
| 2025-06-10 | -4.19 |
| 2025-06-09 | -4.27 |
| 2025-06-06 | -4.19 |
| 2025-06-05 | -4.15 |
| 2025-06-04 | -3.95 |
| 2025-06-03 | -3.95 |
| 2025-06-02 | -3.39 |
| 2025-05-30 | -3.32 |
| 2025-05-29 | -3.24 |
| 2025-05-28 | -3.32 |
| 2025-05-27 | -3.24 |
| 2025-05-23 | -3.34 |
| 2025-05-22 | -3.36 |
| 2025-05-21 | -3.44 |
| 2025-05-20 | -3.32 |
| 2025-05-19 | -3.36 |
| 2025-05-16 | -3.56 |
| 2025-05-15 | -3.30 |
| 2025-05-14 | -3.19 |
| 2025-05-13 | -3.44 |
| 2025-05-12 | -3.44 |
| 2025-05-09 | -3.44 |
| 2025-05-08 | -3.44 |
| 2025-05-07 | -3.49 |
| 2025-05-06 | -3.52 |
| 2025-05-05 | -3.59 |
| 2025-05-02 | -3.72 |
| 2025-05-01 | -3.99 |
| 2025-04-30 | -3.99 |
| 2025-04-29 | -4.43 |
| 2025-04-28 | -4.31 |
| 2025-04-25 | -4.35 |
| 2025-04-24 | -4.59 |
| 2025-04-23 | -4.23 |